Presented at the Transcatheter Cardiovascular Therapeutics conference in San Diego, both trials logged low complication rates ...

Johnson & Johnson has launched its Shockwave C2 Aero Fly coronary intravascular lithotripsy (IVL) catheter in the United ...

A randomized clinical trial at The Mount Sinai Hospital found that combining two techniques for removing calcium ...

Patients with heavily calcified coronary lesions treated with a 2-Hz intravascular lithotripsy catheter have low MACE rates at 1 year.

Johnson & Johnson ( JNJ) said Sunday its investigational Shockwave Javelin coronary intravascular lithotripsy (IVL) catheter exceeded both primary endpoint performance goals in the pivotal FORWARD CAD ...

J&J's Shockwave C2 Aero Fly delivers ultrasonic energy at double the speed of its previous version and with less time between ...

SANTA CLARA, Calif., Oct. 19, 2023 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development and commercialization of transformational technologies for the treatment of ...

SANTA CLARA, Calif., Nov. 09, 2023 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development and commercialization of transformational technologies for the treatment of ...

Johnson & Johnson MedTech’s Shockwave Medical division began rolling out its Javelin system early last month for peripheral artery disease, with a device that emits sonic pressure waves forward from ...

Johnson & Johnson has launched an intravascular lithotripsy catheter that cuts a broad range of calcified coronary artery lesions in half the time compared with previous devices.

Approvals Cover Both Coronary and Peripheral IVL Catheters and Generators Manufactured by Shockwave About Shockwave Medical, Inc.Shockwave is focused on developing and commercializing products ...